跳至主要内容
临床试验/NCT06538441
NCT06538441进行中(未招募)不适用

Dynamic Pattern of Etiology, Immunoinflammatory Factors and Their Association With Prognosis of Severe Pneumonia: a Longitudinal Observational Study

Shanghai General Hospital, China1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2024年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
600
试验地点
1
主要终点
In-hospital mortality

研究概览

简要总结

The goal of this longitudinal observational study is to investigate the pathogen spectrum composition of severe pneumonia (SP) in different disease stages and to study the changes of immune inflammatory factors in patients with SP in different course of disease during and after the COVID-19 pandemic. The main questions it aims to answer is:

What is the pathogenic profile of SP patient admitted in intensive care unit (ICU) during and after COVID-19 pandemic? What is the dynamic pattern of etiology and immunoinflammatory factors of SP progression during the period in ICU? Are those indexes mentioned above associated with the prognosis of SP?

详细描述

This is a multi-center, longitudinal, observational study.

Participants

SP patients will be continuously recruited in ICU department in Shanghai General Hospital and respiratory-specific ICU (RICU) department in the First Affiliated Hospital of Chongqing Medical University during June 1, 2022 to December 31, 2024.

The investigators applied the AmericanThoracic Society(ATS)/Infectious Diseases Society of America (IDSA) major criteria to a cohort of patients hospitalized in two tertiary hospitals with severe pneumonia in order to describe its epidemiology, microbiology, and outcomes.

Assessment of disease progression

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least 18 years of age
  • Clinical diagnosed of severe pneumonia (case definition: adults according to "Diagnosis and Treatment of Adults with Community-acquired Pneumonia"-- An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America, 2019)
  • Have at least one microbiological test result

排除标准

  • No data of clinical prognosis

结局指标

主要结局

In-hospital mortality

时间窗: up to 3 months

Number of Participants with fatal outcomes out of all participants

次要结局

  • length of stay in ICU(through study completion, an average of 38 days)
  • duration of mechanical ventilation(through study completion, an average of 25 days)

研究者

发起方
Shanghai General Hospital, China
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mei Kang

Principal Investigator

Shanghai General Hospital, China

研究点 (1)

Loading locations...

相似试验